Cardioprotective PKG-independent NO signaling at reperfusion

Michael V Cohen1, Xi-Ming Yang, Yanping Liu

  • 1Department of Physiology, University of South Alabama College of Medicine, Mobile, Alabama 36688, USA. mcohen@usouthal.edu

Insights

Nitric oxide (NO) protects the heart during reperfusion independently of PKG, acting downstream of ERK and PI3-kinase. This NO signaling pathway is crucial for ischemic preconditioning (IPC) in intact hearts.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Ischemic Heart Disease

Background:

  • Ischemic preconditioning (IPC) offers cardiac protection during reperfusion, with nitric oxide (NO) implicated.
  • Previous cell models yielded conflicting results regarding NO's role via protein kinase G (PKG).
  • A more physiologically relevant intact heart model is needed to clarify NO's signaling pathway in IPC.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) and its signaling pathways in mediating protection during ischemic preconditioning (IPC) in an intact rabbit heart model.
  • To determine if NO acts independently of protein kinase G (PKG) and downstream of specific kinases like ERK and PI3-kinase.

Main Methods:

  • Isolated rabbit hearts subjected to 30-min coronary artery occlusion followed by 120-min reperfusion.
  • Administration of A(2b) adenosine receptor (A(2b)AR) agonist (BAY 60-6583), PKG activator (CPT-cGMP), and NO donor (SNAP) at reperfusion.
  • Use of pharmacological inhibitors: N(ω)-nitro-l-arginine methyl ester (l-NAME) for NO synthase, wortmannin for PI3-kinase, PD-98059 for ERK, and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) for soluble guanylyl cyclase.

Main Results:

  • Both A(2b)AR agonist and CPT-cGMP reduced infarct size, with protection abolished by l-NAME, indicating a PKG-independent NO synthase.
  • NO donor SNAP also protected against infarction, independent of PI3-kinase and ERK inhibitors, suggesting NO acts downstream of these kinases.
  • NO-mediated protection was independent of PKG, as shown by the lack of effect of ODQ, and involved a second signaling event dependent on NO generation.

Conclusions:

  • Nitric oxide (NO) plays a significant role in the protective mechanisms of ischemic preconditioning (IPC) in intact hearts.
  • NO signaling occurs downstream of ERK and PI3-kinase pathways and is independent of protein kinase G (PKG).
  • This study elucidates a novel NO-dependent, PKG-independent signaling cascade critical for cardiac protection during reperfusion.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...